• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放置依托孕烯植入剂的肿瘤患者行卵巢刺激以保存生育力。

Ovarian stimulation for fertility preservation in an oncology patient with etonogestrel implant in place.

机构信息

Department of Obstetrics and Gynecology, Anschutz Medical Campus, University of Colorado, 12631 E 17th Ave Ste B198-6, Aurora, CO, 80045-2529, USA.

Department of Medicine, Anschutz Medical Campus, University of Colorado, Aurora, CO, USA.

出版信息

J Assist Reprod Genet. 2021 Feb;38(2):513-516. doi: 10.1007/s10815-020-02057-1. Epub 2021 Jan 6.

DOI:10.1007/s10815-020-02057-1
PMID:33409752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7884551/
Abstract

PURPOSE

To describe a case of a young woman who presented for fertility preservation and underwent ovarian stimulation with an etonogestrel implant in place.

METHODS

A 24-year old, gravida 0, with an etonogestrel implant and newly diagnosed lower extremity sarcoma and DVT desiring oocyte cryopreservation prior to adjuvant chemotherapy and radiation. To avoid delay in her oncologic care and allow for continued use of contraception post-retrieval, the patient underwent controlled ovarian hyperstimulation (COH) without removal of the etonogestrel implant.

RESULTS

Baseline labs included follicle-stimulating hormone 9 mIU/mL, luteinizing hormone 4.9 mIU/mL, estradiol 42 pg/mL, anti-Müllerian hormone 5.1 ng/mL, and antral follicle count greater than 40. The patient was placed on an antagonist protocol and stimulated with 125 IU Gonal-F and 75 IU Menopur. She received a total of 12 days of gonadotropin stimulation. On the day of trigger, her estradiol was 1472 pg/mL, lead follicle 21.5 mm with a total of 25 follicles measured > 12 mm. She was triggered with 5000 U hCG. She had a total of 23 oocytes retrieved, 17 of which were metaphase II and vitrified.

CONCLUSIONS

COH and successful oocyte cryopreservation can be achieved in patients with an etonogestrel implant in situ without apparent detrimental effects to oocyte yield or maturity. Due to the etonogestrel implant's inhibitory effects on LH, it is recommended to use an hCG trigger for final oocyte maturation.

摘要

目的

描述一位年轻女性的病例,她因患有下肢肉瘤和深静脉血栓形成,希望在接受辅助化疗和放疗前进行卵子冷冻保存,故前来就诊。该患者已放置左炔诺孕酮宫内节育系统(LNG-IUS),且诊断为 24 岁、初产妇 0 级,我们为其实施了卵巢刺激,使用了左炔诺孕酮宫内节育系统。

方法

为避免延迟肿瘤治疗,并允许在取回后继续使用避孕方法,我们在不取出左炔诺孕酮宫内节育系统的情况下对患者进行控制性卵巢过度刺激(COH)。

结果

基础实验室检查包括卵泡刺激素 9 mIU/mL、黄体生成素 4.9 mIU/mL、雌二醇 42 pg/mL、抗苗勒管激素 5.1 ng/mL 和窦卵泡计数大于 40。患者接受了拮抗剂方案治疗,并接受了 125 IU 果纳芬和 75 IU 美诺孕素的刺激。她接受了总共 12 天的促性腺激素刺激。在触发日,她的雌二醇为 1472 pg/mL,主导卵泡为 21.5 mm,共有 25 个卵泡测量值大于 12 mm。她接受了 5000 U hCG 触发。共取回 23 个卵子,其中 17 个处于中期 II 期并进行了玻璃化冷冻。

结论

在左炔诺孕酮宫内节育系统原位的患者中,可以进行 COH 和成功的卵子冷冻保存,而对卵子产量或成熟度似乎没有明显的不利影响。由于左炔诺孕酮宫内节育系统对 LH 的抑制作用,建议使用 hCG 触发剂进行最终卵子成熟。

相似文献

1
Ovarian stimulation for fertility preservation in an oncology patient with etonogestrel implant in place.放置依托孕烯植入剂的肿瘤患者行卵巢刺激以保存生育力。
J Assist Reprod Genet. 2021 Feb;38(2):513-516. doi: 10.1007/s10815-020-02057-1. Epub 2021 Jan 6.
2
Fertility preservation in an oncology patient who presented with positive human chorionic gonadotropin.一名人绒毛膜促性腺激素呈阳性的肿瘤患者的生育力保存
F S Rep. 2020 Jun 30;1(1):51-53. doi: 10.1016/j.xfre.2020.04.007. eCollection 2020 Jun.
3
Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.在癌症治疗前后,对儿科女性癌症患者进行体外成熟卵母细胞的冷冻保存以及卵巢组织冷冻,以保留生育能力。
Hum Reprod. 2016 Apr;31(4):750-62. doi: 10.1093/humrep/dew007. Epub 2016 Feb 4.
4
Ovarian response to stimulation for fertility preservation in women with hematologic cancer.血液系统恶性肿瘤患者生育力保存的卵巢刺激反应。
J Gynecol Obstet Hum Reprod. 2021 May;50(5):101925. doi: 10.1016/j.jogoh.2020.101925. Epub 2020 Sep 30.
5
Ovarian response after random-start controlled ovarian stimulation to cryopreserve oocytes in cancer patients.癌症患者随机启动控制性卵巢刺激以冷冻保存卵母细胞后的卵巢反应。
JBRA Assist Reprod. 2018 Nov 1;22(4):352-354. doi: 10.5935/1518-0557.20180065.
6
Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.预测促性腺激素释放激素激动剂(GnRHa)触发后卵母细胞成熟的成功诱导。
Hum Reprod. 2013 Jan;28(1):152-9. doi: 10.1093/humrep/des361. Epub 2012 Oct 17.
7
A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.一种简化的体外受精促排卵方案通用方法:采用定制的最终卵泡成熟模式和时间的超短激动剂/拮抗剂联合方案。
J Ovarian Res. 2015 Nov 4;8:69. doi: 10.1186/s13048-015-0198-3.
8
Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation.通过在卵巢刺激开始时测量血清 LH 预测 GnRH 激动剂触发后卵母细胞产量不佳。
Hum Reprod. 2019 Oct 2;34(10):2027-2035. doi: 10.1093/humrep/dez132.
9
Is there a preferred time interval between gonadotropin-releasing hormone (GnRH) agonist trigger and oocyte retrieval in GnRH antagonist cycles? A retrospective cohort of planned fertility preservation cycles.促性腺激素释放激素(GnRH)激动剂扳机与 GnRH 拮抗剂周期中卵母细胞回收之间是否存在首选的时间间隔?一项计划进行生育力保存周期的回顾性队列研究。
J Assist Reprod Genet. 2024 Jun;41(6):1531-1538. doi: 10.1007/s10815-024-03083-z. Epub 2024 Mar 16.
10
Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.与乳腺癌生育力保存候选者相比,霍奇金淋巴瘤患者的窦卵泡对促卵泡激素(FSH)的反应性(通过卵泡排出率(FORT)评估)发生了改变。
J Assist Reprod Genet. 2018 Jan;35(1):91-97. doi: 10.1007/s10815-017-1059-3. Epub 2017 Oct 6.